-
A FRAMEWORK FOR INTEGRATING THE ESTIMANDS INTO FEASIBILITY OF NETWORK META-ANALYSES OF RANDOMIZED CONTROLLED TRIALS
Feb 25, 2026, 14:40 PM -
REAL-WORLD TREATMENT PATTERNS AND TREATMENT INTENSIFICATION IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) BY DISEASE VOLUME AND PRESENTATION
Feb 25, 2026, 14:40 PM -
MODELING APPROACHES FOR VACCINE INDIRECT EFFECTS IN ECONOMIC EVALUATIONS: A SCOPING REVIEW OF PUBLISHED REVIEWS AND METHODOLOGICAL GUIDANCE
Feb 25, 2026, 14:40 PM -
ELICITING CANCER PROGRESSION RATES FOR LOCALLY/REGIONAL RECURRENT (LR) POPULATIONS USING AGGREGATE LEVEL SURVIVAL DATA: AN ILLUSTRATION FROM MELANOMA
Feb 25, 2026, 14:40 PM -
A NOVEL MULTIVARIATE APPLICATION OF PROFILE ANALYSIS TO CHARACTERIZE MULTIDOMAIN PATIENT-REPORTED OUTCOME (PRO) PATTERNS IN PATIENTS WITH GASTRIC OR GASTROESOPHAGEAL JUNCTION (GC/GEJC) ADENOCARCINOMA
Feb 25, 2026, 14:40 PM -
ACCESSIBILITY OF ANTI-TUBERCULOSIS DRUGS ON THE PHARMACEUTICAL MARKET IN THE ASIA-PACIFIC REGION BETWEEN 2019 AND 2022
Feb 25, 2026, 14:40 PM -
STRATEGIC COMPARISON OF CENTER FOR PHARMACOECONOMICS AND INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW ECONOMIC EVALUATIONS
Feb 25, 2026, 14:40 PM -
METHODOLOGICAL DIVERGENCE AND POLICY IMPACT OF HTAS FOR IMMUNE CHECKPOINT INHIBITORS IN NSCLC
Feb 25, 2026, 14:40 PM -
HEALTHCARE RESOURCE UTILIZATION (HCRU) IN PEDIATRIC PATIENTS WITH HEREDITARY ANGIOEDEMA (HAE) IN THE UNITED STATES: A MATCHED STUDY USING LARGE INSURANCE CLAIMS
Feb 25, 2026, 14:40 PM -
VALUE-BASED PURCHASING ARRANGEMENTS IN MEDICAID: A TARGETED LITERATURE REVIEW
Feb 25, 2026, 14:40 PM -
CHARACTERIZING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) LONGITUDINAL EHR ACTIVITY USING A LARGE US ELECTRONIC HEALTH RECORDS DATABASE LINKED TO CLAIMS, 2020-2025
Feb 25, 2026, 14:40 PM -
MARKOV MODEL-BASED COST-UTILITY ANALYSIS COMPARING RANIBIZUMAB WITH PANRETINAL PHOTOCOAGULATION FOR PROLIFERATIVE DIABETIC RETINOPATHY IN INDIA
Feb 25, 2026, 14:40 PM -
WHEN ONE CODE DEFINES MILLIONS: SENSITIVITY OF PERIPHERAL ARTERY DISEASE COHORTS TO OPERATIONAL DEFINITIONS CHOICES IN REAL-WORLD DATA
Feb 25, 2026, 14:40 PM -
THE FUTURE OF EVIDENCE SYNTHESIS AND GENERATION IN HEOR: A SECURE FRAMEWORK FOR DOMAIN SPECIFIC ADAPTATION AND FINE-TUNING OF LARGE LANGUAGE MODELS
Feb 25, 2026, 14:40 PM -
FACTORS ASSOCIATED WITH OVERDOSE RISK AMONG PERINATAL WOMEN WITH OPIOID USE DISORDER
Feb 25, 2026, 14:40 PM -
COMPARATIVE EFFECTIVENESS AND SAFETY OF EAST ASIAN TRADITIONAL MEDICINE FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN CHILDREN: A SYSTEMATIC REVIEW AND BAYESIAN NETWORK META-ANALYSIS
Feb 25, 2026, 14:40 PM -
TRENDS IN GUIDELINE-DIRECTED MEDICAL THERAPY AMONG PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
Feb 25, 2026, 14:40 PM -
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS AND RISK OF PARKINSON’S DISEASE IN PATIENTS WITH OBESITY
Feb 25, 2026, 14:40 PM -
ENHANCING REAL-WORLD DATA COMPLETENESS IN TYPE 2 DIABETES THROUGH LINKAGE OF CLAIMS, EMR, AND LABORATORY DATA
Feb 25, 2026, 14:40 PM -
COST-EFFECTIVENESS AND BUDGET IMPACT OF CAFFEINE CITRATE VERSUS AMINOPHYLLINE FOR APNEA OF PREMATURITY ACROSS A PUBLIC HEALTHCARE SYSTEM IN MEXICO
Feb 25, 2026, 14:40 PM
